<DOC>
	<DOCNO>NCT02735499</DOCNO>
	<brief_summary>Instillation treatment onabotulinumtoxin A ( BOTOX速 ) urinary bladder</brief_summary>
	<brief_title>Instillation Botox Bladder</brief_title>
	<detailed_description>Pilot study evaluate effect instillation treatment onabotulinumtoxin A ( BOTOX速 ) urinary bladder use Electromotive Drug Application ( EMDA ) woman overactive bladder . 15 woman therapy-resistant OAB include . All patient must qualify conventional cystoscopic Botox injection . The study randomize blind . Follow-up time six month void chart three questionnaire . ( UDI-6 , IIQ-7 , ICIQ-UI SF ) well satisfaction treatment VAS .</detailed_description>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Informed consent form sign OAB/urgency incontinence least 3 month duration Conservative treatment ( medicine , electrical stimulation ) try without sufficient benefit There indication cystoscopic injection treatment Botox速 More 3months since previous treatment Botox速 Detrusor overactivity document cystometry desirable , obligatory Age 18 year Mixed incontinence predominant stress component Insuffcient understanding Norwegian / unable fill necessary form Ongoing urinary tract infection ( UTI ) ( define positive urine stix ( nitrite leucocyte ) symptoms UTI ) must treat inclusion . Any contraindication state SPC Botox</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>onabotulinum toxin A</keyword>
	<keyword>Urinary bladder</keyword>
	<keyword>EMDA</keyword>
	<keyword>iontophoresis</keyword>
	<keyword>electrophoresis</keyword>
	<keyword>Urinary incontinence</keyword>
</DOC>